primary or spontaneous bacterial peritonitis (SBP)

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

Pathology

Clinical manifestations

Laboratory

Complications

  • mortality 10-20%[3]

Management

More general terms

Additional terms

References

  1. Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 275, 276, 312, 378
  2. Jump up to: 2.0 2.1 Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 326
  3. Jump up to: 3.0 3.1 3.2 3.3 3.4 3.5 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16, 17. American College of Physicians, Philadelphia 1998, 2009, 2012, 2015
  4. Jump up to: 4.0 4.1 Talwalker JA & Kamath PS, Influence of recent advances in medical management on clinical outcomes of cirrhosis Mayo Clin Proc 80(11):1501, 2005 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16295030
  5. Jump up to: 5.0 5.1 Goel GA et al. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol 2012 Apr; 10:422 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22155557
  6. Runyon BA; AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009 Jun;49(6):2087-107 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19475696
  7. Runyon BA; AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013 Apr;57(4):1651-3 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23463403
  8. Jump up to: 8.0 8.1 European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 Apr 10. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29653741 https://www.journal-of-hepatology.eu/article/S0168-8278(18)31966-4/fulltext
  9. Jump up to: 9.0 9.1 Yim HJ, Suh SJ, Jung YK et al. Daily norfloxacin vs. weekly ciprofloxacin to prevent spontaneous bacterial peritonitis: A randomized controlled trial. Am J Gastroenterol 2018 Aug; 113:1167 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29946179 https://www.nature.com/articles/s41395-018-0168-7
  10. Jump up to: 10.0 10.1 Komolafe O, Roberts D, Freemasn SC et al. Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: A network meta-analysis. Cochrane Database Syst Rev 2020 Jan 16; 1:CD013125 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31978256 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013125.pub2/full
  11. Jump up to: 11.0 11.1 Biggins SW et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021 Aug; 74:1014 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33942342 https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31884
  12. Jump up to: 12.0 12.1 Nanchal R et al. Executive Summary: Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: Neurology, peri-transplant medicine, infectious disease, and gastroenterology considerations. Crit Care Med 2023 May; 51:653. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37052435 https://journals.lww.com/ccmjournal/Fulltext/2023/05000/Executive_Summary__Guidelines_for_the_Management.10.aspx
  13. Jump up to: 13.0 13.1 NEJM Knowledge+
    Sort P, Navasa M, Arroyo V et al Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999 Aug 5;341(6):403-9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/10432325 Free article https://www.nejm.org/doi/pdf/10.1056/NEJM199908053410603